# US Metabolomics Services Market

> US Metabolomics Services Market Research Report By Product Type (Chromatography, Metabolomics Bioinformatics Services, Mass Spectrometry) and By Application (Biomedical and Pharmaceutical, Agriculture, Food) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.18%
- **2024:** $ 80 Million
- **2025:** $ 86.54 Million
- **2035:** $ 190 Million
- **Key Players:** Metabolon Inc (US), Biocrates Life Sciences AG (AT), Agilent Technologies Inc (US), Thermo Fisher Scientific Inc (US), Waters Corporation (US), PerkinElmer Inc (US), Sierra Analytics Inc (US), Creative Proteomics (US)

**Report ID:** MRFR/HC/17888-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-metabolomics-services-market-19435

---

## Market Summary

## **US Metabolomics Services Market Overview**

As per MRFR analysis, the US Metabolomics Services Market Size was estimated at 641.9 (USD Million) in 2023. The US Metabolomics Services Market Industry is expected to grow from 720.3(USD Million) in 2024 to 3,021.2 (USD Million) by 2035. The US Metabolomics Services Market CAGR (growth rate) is expected to be around 13.922% during the forecast period (2025 - 2035).

### **Key US Metabolomics Services Market Trends Highlighted**

The US Metabolomics Services Market is witnessing significant growth driven by various factors. One of the key market drivers is the increasing focus on personalized medicine, which requires a better understanding of individual metabolic profiles. Research institutions and clinical laboratories in the US are increasingly investing in metabolomics to enhance drug development and discover new biomarkers for diseases.

Furthermore, the growing prevalence of chronic diseases, coupled with the demand for precision health solutions, is pushing healthcare providers to adopt metabolomics technologies. Opportunities to be explored include collaborations between academic institutions and private laboratories to advance metabolomics research, which can lead to innovative service offerings in the market.

The increasing availability of advanced analytical technologies, such as mass spectrometry and nuclear magnetic resonance, shows potential for expanded applications in metabolomics research and clinical diagnostics. Emerging areas such as plant metabolomics and environmental metabolomics are also attracting attention and providing new avenues for service providers to consider.

In recent times, funding for metabolomics research projects has increased, thanks in part to government initiatives promoting advanced healthcare technologies. Additionally, the growing trend toward integrating big data analytics and artificial intelligence in metabolomics is shaping the future of this market by enhancing data interpretation and improving decision-making processes.

The rise in health awareness among the US population also contributes to the demand for metabolomics services, as consumers seek more comprehensive health solutions. Overall, these trends suggest a dynamic and evolving landscape for the US Metabolomics Services Market.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Metabolomics Services Market Drivers**

### **Growing Incidence of Chronic Diseases Increases Demand**

In the United States, the rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer drives the growth of the US Metabolomics Services Market Industry. The Centers for Disease Control and Prevention (CDC) have reported that nearly 60% of adults in the US are living with at least one chronic disease, and this number is expected to rise due to an aging population and lifestyle factors.

The integration of metabolomics into personalized medicine allows for early diagnosis and better disease management, making metabolomics services a critical component in healthcare. Established organizations like the American Heart Association and the American Cancer Society advocate using innovative technologies such as metabolomics to improve patient outcomes, effectively increasing the demand for these services.

This surge in interest and necessity within the healthcare sector acts as a pivotal driver for the Metabolomics Services Market in the US.

### **Advancements in Technological Capabilities**

Technological advancements significantly enhance the sensitivity, specificity, and throughput of metabolomics technologies, including mass spectrometry and nuclear magnetic resonance spectroscopy. The National Institutes of Health (NIH) has highlighted that in recent years, funding for Research and Development in bioanalytical technologies has increased, supporting innovations in this field.

For instance, higher resolution instruments now enable the detection of more metabolites in human samples, creating a wider application spectrum for metabolomics services across various industries, including pharmaceuticals and environmental analysis. As more laboratories acquire cutting-edge equipment, the availability and use of metabolomics services in the US correspondingly expand, further propelling market growth.

### **Increased Investment in Personalized Medicine**

The growing shift towards personalized medicine in the United States underpins the expansion of the US Metabolomics Services Market Industry. The ongoing trend of tailoring medical treatments to individual patient profiles, particularly for complex diseases, necessitates deeper insights into metabolic pathways.

According to the National Cancer Institute, personalized approaches can improve treatment efficacy, thus increasing the demand for tailored metabolic profiling services. Pharmaceutical companies are actively investing in technologies and services that enable personalized approaches, driving significant growth in the metabolomics sector.

The continuous push for advanced, data-driven healthcare solutions strengthens the market, as established organizations increasingly incorporate metabolomic assessments into their research pipelines.

## **US Metabolomics Services Market Segment Insights**

### **Metabolomics Services Market Product Type Insights**

The US Metabolomics Services Market has been experiencing significant growth driven by the increasing application of metabolomics in Research and Development, clinical diagnostics, and personalized medicine. Within the Product Type segment, key services such as Chromatography, Metabolomics Bioinformatics Services, and Mass Spectrometry play crucial roles in advancing research and diagnostics.

Chromatography methods have become vital for separating complex mixtures of metabolites, thereby enhancing the accuracy and efficiency of metabolite analysis. The significance of Chromatography lies in its vast usability across numerous research disciplines, allowing scientists to explore metabolic pathways and their implications in various diseases.

This method has been instrumental in drug development and environmental research by helping researchers better understand the behavior of substances in biological systems. Metabolomics Bioinformatics Services, on the other hand, are experiencing a growing demand as the need for adequate data analysis becomes increasingly apparent.

These services are crucial for interpreting complex data generated by metabolomics studies, thus facilitating researchers' ability to draw meaningful conclusions from their findings. With the rapid advancement of genomic and proteomic technologies, the synergy between bioinformatics and metabolomics is likely to lead to improved insights in disease mechanisms and therapeutic targets, making it an essential component of the Metabolomics Services Market.

Mass Spectrometry, known for its high sensitivity and specificity in identifying and quantifying metabolites, continues to dominate as a preferred analytical technique. Its ability to analyze small molecules and provide comprehensive metabolic profiles contributes significantly to its importance. The precision of Mass Spectrometry makes it a critical tool in the identification of biomarkers for diseases, thereby advancing personalized medicine initiatives across the United States.

All these factors underscore the robust potential of the US Metabolomics Services Market and indicate a promising future driven by technological advancements and increasing investments in metabolomics research.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Metabolomics Services Market Application Insights**

The Application segment of the US Metabolomics Services Market showcases a diverse array of uses that underline its significance in advancing scientific research and industry practices. The Biomedical and Pharmaceutical sectors are particularly vital, as they benefit from metabolomics in drug development and personalized medicine, helping to identify biomarkers and tailor treatments to individual patient profiles.

In Agriculture, metabolomics plays a crucial role in improving crop yield and quality, enabling the identification of plant metabolites linked to stress resistance and subsequent enhancement of agricultural practices. The Food industry also emphasizes metabolomics to ensure quality control and food safety, as well as to analyze nutritional content and flavor profiles.

This multi-faceted application of metabolomics services is driving innovation across numerous fields, substantiating the growing emphasis on data-driven decisions in both research and commercial sectors in the US. With the increasing integration of metabolomics in various industries, this segment is poised for considerable growth, reflecting the overall trends of the US Metabolomics Services Market.

Additionally, the intersection of technology advancements and heightened awareness for health and safety standards creates numerous opportunities for expansion within these applications, further illustrating their importance in the evolving landscape.

## **US Metabolomics Services Market Key Players and Competitive Insights**

The US Metabolomics Services Market has witnessed significant growth in recent years, driven by advancements in analytical technologies and the increasing adoption of metabolomics in various applications including drug development, personalized medicine, and biomarker discovery. Companies operating in this space emphasize the development of innovative solutions and robust service portfolios to address the needs of researchers and healthcare professionals.

This competitive landscape is characterized by a mix of established firms and emerging players, with collaborations and partnerships playing a critical role in enhancing service offerings and expanding market reach. The growing awareness of the importance of metabolic profiling has further intensified competition, leading to more strategic initiatives across the sector.

Biocrates Life Sciences has positioned itself as a leader within the US Metabolomics Services Market by leveraging its strengths in high-throughput analysis and a strong proprietary platform designed for targeted metabolomics. The company is well-regarded for its sophisticated technology that enables precise quantification of metabolites across a wide range of biological samples.

With a focus on delivering high-quality services tailored to meet regulatory standards, Biocrates Life Sciences has forged strong partnerships with research institutions and industrial stakeholders to enhance its market presence. The organization's commitment to maintaining a robust service pipeline ensures that it remains competitive in the evolving landscape of metabolic research, thereby allowing customers to generate impactful insights into their biological questions.

Yale University plays a pivotal role within the US Metabolomics Services Market, particularly through its comprehensive research capabilities and the innovative use of metabolomics in various scientific investigations. The university provides a suite of services, including access to state-of-the-art analytical facilities and expertise in metabolite identification and quantification.

Yale's strengths lie in its collaborative environment, fostering partnerships with both academic and commercial entities, facilitating knowledge transfer and expanding its market reach. The institution has effectively integrated metabolomics into research across different disciplines, contributing significantly to advancements in personalized medicine and drug discovery.

Furthermore, Yale has a strategic focus on developing novel methodologies and collaborative research projects, which fortify its competitive position in the metabolomics landscape while continuously contributing to scientific advancements in the US region.

### **Key Companies in the US Metabolomics Services Market Include**

## **US Metabolomics Services Market Industry Developments**

The US Metabolomics Services Market has seen significant developments recently, driven by increased research funding and technological advancements. Companies such as Metabolon, Thermo Fisher Scientific, and Bruker Corporation have expanded their service offerings, primarily focusing on metabolic profiling and biomarker discovery, responding to the growing demand from pharmaceutical and biotechnology sectors.

In terms of current affairs, the market is experiencing a surge in interest due to the application of metabolomics in personalized medicine and drug development, with institutions like Yale University and the University of California leading innovative research initiatives.

In the realm of mergers and acquisitions, Biocrates Life Sciences announced a strategic partnership with Waters Corporation in June 2023 to enhance their metabolomics capabilities, which signifies the trend of consolidation in the industry. Additionally, MilliporeSigma and Ceres Media have been collaborating on projects to develop advanced analytics in metabolomics.

Over the past few years, notable growth in market valuation has been reported, with estimates indicating an increase in market size exceeding 20% from 2021 to 2023, fueled by rising healthcare expenditures and a growing emphasis on precision medicine.

## **US Metabolomics Services Market Segmentation Insights**

### **Metabolomics Services Market Product Type Outlook**

### **Metabolomics Services Market Application Outlook**

## Market Drivers

### Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases in the US is a significant driver for the metabolomics services market. Conditions such as diabetes, cardiovascular diseases, and cancer are becoming more prevalent, necessitating advanced diagnostic and therapeutic approaches. Metabolomics offers a unique perspective on disease mechanisms, allowing for the identification of metabolic biomarkers that can aid in early diagnosis and personalized treatment strategies. According to recent statistics, chronic diseases account for approximately 70% of all deaths in the US, highlighting the urgent need for effective management solutions. This growing health crisis is likely to stimulate demand for metabolomics services, as healthcare providers seek innovative ways to improve patient outcomes. the market is expected to expand as healthcare systems increasingly adopt metabolomics to enhance disease management and treatment efficacy.

### Growing Investment in Research and Development

The metabolomics services market is experiencing a surge in investment, particularly in research and development (R&D) initiatives. This trend is driven by the increasing recognition of metabolomics as a critical tool in drug discovery, biomarker identification, and disease understanding. In the US, funding from both public and private sectors has escalated, with R&D expenditures in the life sciences reaching approximately $200 billion annually. This influx of capital is likely to enhance the capabilities of metabolomics services, enabling more sophisticated analyses and applications. As a result, the market is poised for growth, with an expected CAGR of around 12% over the next five years. The focus on innovative methodologies and technologies in R&D is expected to propel the metabolomics services market forward, fostering advancements that could lead to breakthroughs in various health-related fields.

### Advancements in Data Analysis and Bioinformatics

The metabolomics services market is being significantly influenced by advancements in data analysis and bioinformatics. As the volume of data generated from metabolomic studies increases, the need for sophisticated analytical tools becomes paramount. Innovations in machine learning and artificial intelligence are enabling researchers to extract meaningful insights from complex datasets, thereby enhancing the utility of metabolomics in various applications. In the US, the bioinformatics market is projected to reach $10 billion by 2026, indicating a robust growth trajectory that will likely benefit the metabolomics services market. These advancements not only improve the accuracy of metabolomic analyses but also facilitate the integration of metabolomics with other omics technologies, creating a more comprehensive understanding of biological systems. Consequently, the market is expected to thrive as these technologies become more accessible and user-friendly.

### Regulatory Support for Metabolomics Applications

Regulatory bodies in the US are increasingly recognizing the potential of metabolomics in various applications, including drug development and clinical diagnostics. This regulatory support is fostering an environment conducive to the growth of the metabolomics services market. Initiatives aimed at streamlining the approval processes for metabolomic-based products and services are being implemented, which may enhance market accessibility. For instance, the FDA has shown interest in incorporating metabolomic data into its regulatory frameworks, potentially expediting the approval of new therapies. This supportive regulatory landscape is likely to encourage investment and innovation within the metabolomics services market, as companies seek to leverage these opportunities. As regulations evolve, the market could witness a surge in the adoption of metabolomics technologies across different sectors, further driving growth.

### Rising Awareness of Metabolomics in Clinical Research

There is a growing awareness of the role of metabolomics in clinical research, which is significantly impacting the metabolomics services market. Researchers and clinicians are increasingly recognizing the value of metabolomic profiling in understanding disease mechanisms and developing targeted therapies. Educational initiatives and conferences are promoting the benefits of metabolomics, leading to a broader acceptance of its applications in clinical settings. In the US, the number of publications related to metabolomics has increased by over 30% in recent years, reflecting the expanding interest in this field. This heightened awareness is likely to drive demand for metabolomics services, as more institutions seek to incorporate these analyses into their research protocols. As the understanding of metabolomics continues to evolve, the market is expected to grow, with an increasing number of collaborations between academic institutions and service providers.

## Future Outlook

The [Metabolomics Services Market](https://www.marketresearchfuture.com/reports/metabolomics-services-market-8435) is projected to grow at 8.18% CAGR from 2025 to 2035, driven by advancements in technology, increasing research funding, and rising demand for personalized medicine.

**New opportunities:**

- Development of integrated metabolomics platforms for clinical diagnostics.
- Expansion of metabolomics applications in agricultural biotechnology.
- Partnerships with pharmaceutical companies for drug discovery and development.

By 2035, the metabolomics services market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Product and Service: Chromatography (Largest) vs. Metabolomics Bioinformatics Services (Fastest-Growing)

In the US metabolomics services market, the product and service segment comprises various analytical techniques, with Chromatography leading in market share. It is predominantly preferred for its reliability in separating and analyzing complex mixtures of metabolites. On the other hand, Metabolomics Bioinformatics Services have gained substantial traction, indicating an emerging trend where companies are increasingly looking for integrated data analysis solutions to complement their laboratory capabilities.

The growth trends within this segment are driven by the rise in personalized medicine and the need for comprehensive data interpretation. As research and development activities expand, the demand for advanced analytical methods like Mass Spectrometry is anticipated to grow steadily. Additionally, the integration of AI and machine learning in bioinformatics services is propelling their rapid growth, making them a pivotal player in the market.

Chromatography (Dominant) vs. Metabolomics Bioinformatics Services (Emerging)

Chromatography remains the dominant method in the US metabolomics services market due to its effectiveness in separating compounds, making it indispensable for various applications in clinical research and diagnostics. Its extensive use in laboratories reflects its reliability and versatility in handling diverse sample types. In contrast, Metabolomics Bioinformatics Services represent an emerging trend, facilitating data analysis and interpretation that are critical for understanding complex biological systems. As the demand for tailored therapeutic solutions rises, these bioinformatics services are becoming vital, complementing traditional analytical methods by providing valuable insights and enhancing research efficacy.

### By Application: Biomedical and Pharmaceutical (Largest) vs. Agriculture (Fastest-Growing)

In the US metabolomics services market, the application segments are distributed among various fields such as biomedical and pharmaceutical, agriculture, and food. The biomedical and pharmaceutical segment holds the largest market share due to its critical role in drug development and personalized medicine. This sector’s demand is driven by the need for advanced analytical techniques to understand metabolic profiles, which are essential in disease marker discovery and therapeutic research.

On the other hand, the agriculture segment is recognized as the fastest-growing application area within the market. This growth is propelled by increasing concerns over food safety and quality, alongside a rising demand for sustainable agricultural practices. The integration of metabolomics in agriculture allows for enhanced crop management and the development of biofortified crops, making this segment vital for future food security.

Biomedical and Pharmaceutical (Dominant) vs. Agriculture (Emerging)

The biomedical and pharmaceutical segment is dominant in the US metabolomics services market, characterized by its extensive reliance on metabolic profiling to facilitate drug discovery and development. This sector is critical for identifying biomarkers that aid in understanding diseases and tailoring treatments. In contrast, the agriculture segment is emerging as a key player, leveraging metabolomics techniques to improve crop yields and resilience against pests and diseases. The use of metabolomics in agriculture supports the development of biofertilizers and biopesticides, promoting sustainable farming practices. As consumer preferences shift towards healthier and safer food options, both segments will continue to evolve, but biomedical and pharmaceutical applications currently exhibit more extensive market penetration.

## Competitive Benchmarking

The metabolomics services market is currently characterized by a dynamic competitive landscape, driven by advancements in technology and increasing demand for personalized medicine. Key players such as Metabolon Inc (US), Agilent Technologies Inc (US), and Thermo Fisher Scientific Inc (US) are at the forefront, leveraging innovation and strategic partnerships to enhance their service offerings. Metabolon Inc (US) focuses on expanding its capabilities in biomarker discovery and clinical applications, which positions it favorably in the growing field of precision medicine. Meanwhile, Agilent Technologies Inc (US) emphasizes its commitment to integrating cutting-edge analytical technologies, thereby enhancing its competitive edge in metabolomics research and applications. These strategies collectively contribute to a robust competitive environment, where innovation and operational efficiency are paramount.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance service delivery and reduce costs. The market appears moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. This competitive structure allows for a diverse range of services and innovations, fostering an environment where smaller firms can also thrive alongside industry giants.

In October  Metabolon Inc (US) announced a strategic partnership with a leading pharmaceutical company to develop novel metabolomic biomarkers for drug response. This collaboration is expected to enhance Metabolon's capabilities in personalized medicine, potentially leading to improved patient outcomes and a stronger market position. The strategic importance of this partnership lies in its potential to accelerate the development of targeted therapies, aligning with the industry's shift towards precision medicine.

In September  Thermo Fisher Scientific Inc (US) launched a new suite of metabolomics tools designed to streamline data analysis and enhance user experience. This initiative reflects the company's commitment to digital transformation and innovation in analytical technologies. By simplifying the workflow for researchers, Thermo Fisher aims to solidify its leadership position in the metabolomics services market, catering to the growing demand for efficient and effective research solutions.

In August  Agilent Technologies Inc (US) expanded its metabolomics service offerings by acquiring a specialized analytics firm. This acquisition is likely to enhance Agilent's capabilities in data analytics and interpretation, which are critical for advancing metabolomics research. The strategic move underscores Agilent's focus on integrating advanced analytics into its service portfolio, thereby addressing the increasing complexity of metabolomic data.

As of November  current trends in the metabolomics services market include a pronounced emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into research methodologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies that prioritize these areas will likely emerge as leaders in the metabolomics services market.

## Recent News & Developments

The US Metabolomics Services Market has seen significant developments recently, driven by increased research funding and technological advancements. Companies such as Metabolon, Thermo Fisher Scientific, and Bruker Corporation have expanded their service offerings, primarily focusing on metabolic profiling and biomarker discovery, responding to the growing demand from pharmaceutical and biotechnology sectors.

In terms of current affairs, the market is experiencing a surge in interest due to the application of metabolomics in personalized medicine and drug development, with institutions like Yale University and the University of California leading innovative research initiatives.

In the realm of mergers and acquisitions, Biocrates Life Sciences announced a strategic partnership with Waters Corporation in June 2023 to enhance their metabolomics capabilities, which signifies the trend of consolidation in the industry. Additionally, MilliporeSigma and Ceres Media have been collaborating on projects to develop advanced analytics in metabolomics.

Over the past few years, notable growth in market valuation has been reported, with estimates indicating an increase in market size exceeding 20% from 2021 to 2023, fueled by rising healthcare expenditures and a growing emphasis on precision medicine.

## Report Scope

| MARKET SIZE 2024 | 80.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 86.54(USD Million) |
| MARKET SIZE 2035 | 190.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.18% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Metabolon Inc (US), Biocrates Life Sciences AG (AT), Agilent Technologies Inc (US), Thermo Fisher Scientific Inc (US), Waters Corporation (US), PerkinElmer Inc (US), Sierra Analytics Inc (US), Creative Proteomics (US) |
| Segments Covered | Product and Service, Application |
| Key Market Opportunities | Advancements in personalized medicine drive demand for innovative metabolomics services solutions. |
| Key Market Dynamics | Rising demand for personalized medicine drives innovation and competition in the metabolomics services market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US metabolomics services market in 2024?**
A: The market valuation was $80.0 Million in 2024.

**Q: What is the projected market valuation for the US metabolomics services market by 2035?**
A: The projected valuation for 2035 is $190.0 Million.

**Q: What is the expected CAGR for the US metabolomics services market during the forecast period 2025 - 2035?**
A: The expected CAGR is 8.18% during the forecast period 2025 - 2035.

**Q: Which companies are considered key players in the US metabolomics services market?**
A: Key players include Metabolon Inc, Biocrates Life Sciences AG, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Waters Corporation, PerkinElmer Inc, Sierra Analytics Inc, and Creative Proteomics.

**Q: What are the main product and service segments in the US metabolomics services market?**
A: The main segments include Chromatography, Metabolomics Bioinformatics Services, and Mass Spectrometry.

**Q: What was the valuation of the Metabolomics Bioinformatics Services segment in 2024?**
A: The valuation for the Metabolomics Bioinformatics Services segment was $30.0 Million in 2024.

**Q: What applications are driving growth in the US metabolomics services market?**
A: Key applications include Biomedical and Pharmaceutical, Agriculture, and Food.

**Q: What was the valuation of the Biomedical and Pharmaceutical application segment in 2024?**
A: The valuation for the Biomedical and Pharmaceutical application segment was $40.0 Million in 2024.

**Q: How does the valuation of the Agriculture application segment compare to others in 2024?**
A: The Agriculture application segment had a valuation of $20.0 Million, which is lower than Biomedical and Pharmaceutical and Food segments.

**Q: What is the expected growth trend for the Mass Spectrometry segment in the US metabolomics services market?**
A: The Mass Spectrometry segment is projected to grow from $30.0 Million to $70.0 Million during the forecast period 2025 - 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-metabolomics-services-market-19435*